Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymalfasin and IL-2 for Lymphocytopenia in Hematological Malignancies
NCT06584006Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- Sep 2024
- Primary completion
- Nov 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of thymosin alpha 1 in lymphocytopenia, sponsored by First Affiliated Hospital of Xiamen University. Started Sep 2024; status: recruiting.
02
Drugs
thymosin alpha 1
03
Conditions
lymphocytopenia
Beyond the preview
Go deeper on NCT06584006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06584006.